trending Market Intelligence /marketintelligence/en/news-insights/trending/CxTDNe77GAOcCFff0eJLfw2 content esgSubNav
In This List

Kitov Pharma prices $6M registered direct offering of American depositary shares

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Kitov Pharma prices $6M registered direct offering of American depositary shares

Kitov Pharma Ltd. priced a registered direct offering of 3,428,572 American depositary shares at $1.75 apiece.

The Israeli drug developer expects to raise $6 million in gross proceeds from the offering.

Kitov Pharma will also issue unregistered warrants to purchase up to 2,571,430 ADSs. Each warrant can be exercised at $2 per ADS for a period of five and a half years.

H.C. Wainwright & Co. is the exclusive placement agent for the offering.

Tel Aviv, Israel-based Kitov Pharma expects to close the offering on or about Jan. 18 subject to closing conditions.